Table 2.

Prevalence of obesity, ATP-III MetS, and diabetes by age range and US region

Age group	N	Obesity		ATP-III MetS		Diabetes
		%	95 CI	%	95 CI	%	95 CI
New England
20–39	116	17.7	(9.1, 26.4)	12.8	(5.3, 20.2)	1.0	(0.0, 2.5)
40–65	193	34.9	(26.8, 43.0)	38.5	(30.0, 47.0)	6.4	(3.6, 9.3)
Mid-Atlantic
20–39	534	26.1	(21.0, 31.2)	18.8	(14.2, 23.3)	4.4	(3.1, 5.8)
40–65	731	36.6	(31.5, 41.7)	38.4	(32.5, 44.3)	12.2	(8.7, 15.6)
East North Central
20–39	632	28.8	(24.1, 33.5)	18.8	(15.2, 22.4)	2.6	(1.3, 3.9)
40–65	769	39.6	(35.8, 43.4)	44.9	(40.9, 49.0)	14.0	(11.8, 16.2)
West North Central
20–39	194	27.2	(17.8, 36.5)	26.8	(18.1, 35.6)	1.5	(0.0, 3.0)
40–65	348	42.0	(35.5, 48.5)	47.0	(38.5, 55.5)	13.0	(9.1, 16.9)
South Atlantic
20–39	878	29.3	(24.9, 33.7)	17.6	(14.5, 20.8)	2.3	(1.2, 3.4)
40–65	1241	37.4	(33.0, 41.8)	42.2	(38.7, 45.8)	10.4	(8.3, 12.5)
East South Central
20–39	110	36.2	(22.8, 49.5)	27.3	(19.3, 35.2)	1.2	(0.0, 2.7)
40–65	159	38.0	(24.2, 51.7)	43.9	(32.6, 55.1)	15.9	(10.1, 21.7)
West South Central
20–39	600	35.8	(28.3, 43.3)	23.5	(17.3, 29.7)	3.1	(1.3, 4.9)
40–65	832	40.6	(35.1, 46.2)	45.7	(39.9, 51.5)	12.1	(9.6, 14.7)
Mountain
20–39	306	26.2	(19.9, 32.4)	20.3	(16.5, 24.1)	1.7	(0.0, 3.6)
40–65	374	27.1	(22.3, 31.9)	39.9	(33.6, 46.2)	10.7	(4.8, 16.6)
Pacific
20–39	772	29.5	(25.3, 33.6)	18.7	(15.2, 22.3)	2.6	(1.2, 4.0)
40–65	1037	35.7	(31.8, 39.6)	38.3	(34.7, 41.8)	11.5	(8.7, 14.4)